Bonus Biogroup (BONS) — Net Asset Quality Index
Bonus Biogroup (BONS) has a Net Asset Quality Index of -36.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA15.44 Million minus total liabilities of ILA21.11 Million yields net assets of ILA-5.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check BONS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bonus Biogroup Net Asset Quality Index Over Time (2008–2025)
This chart shows how Bonus Biogroup's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the index stands at -36.7%, representing net assets of ILA-5.66 Million against total assets of ILA15.44 Million ILA. See BONS working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Bonus Biogroup (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Bonus Biogroup from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Bonus Biogroup market cap and net worth.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -36.7% | ILA-5.66 Million | ILA15.44 Million | ILA21.11 Million | ▼ -66.4 pp |
| 2024 | 29.7% | ILA6.96 Million | ILA23.41 Million | ILA16.45 Million | ▼ -35.6 pp |
| 2023 | 65.3% | ILA29.30 Million | ILA44.89 Million | ILA15.58 Million | ▼ -10.3 pp |
| 2022 | 75.6% | ILA56.39 Million | ILA74.61 Million | ILA18.22 Million | ▼ -5.4 pp |
| 2021 | 80.9% | ILA84.43 Million | ILA104.32 Million | ILA19.89 Million | ▲ +21.3 pp |
| 2020 | 59.7% | ILA30.68 Million | ILA51.44 Million | ILA20.75 Million | ▲ +255.9 pp |
| 2019 | -196.3% | ILA-13.72 Million | ILA6.99 Million | ILA20.71 Million | ▼ -165.0 pp |
| 2018 | -31.3% | ILA-3.18 Million | ILA10.16 Million | ILA13.34 Million | ▲ +83.2 pp |
| 2017 | -114.5% | ILA-6.38 Million | ILA5.58 Million | ILA11.96 Million | ▲ +139.8 pp |
| 2016 | -254.2% | ILA-7.36 Million | ILA2.90 Million | ILA10.26 Million | ▼ -230.1 pp |
| 2015 | -24.1% | ILA-1.39 Million | ILA5.76 Million | ILA7.14 Million | ▼ -37.5 pp |
| 2014 | 13.4% | ILA604.00K | ILA4.52 Million | ILA3.92 Million | ▼ -65.7 pp |
| 2013 | 79.0% | ILA6.45 Million | ILA8.16 Million | ILA1.71 Million | ▼ -5.4 pp |
| 2012 | 84.4% | ILA7.47 Million | ILA8.85 Million | ILA1.38 Million | ▲ +8894.4 pp |
| 2011 | -8810.0% | ILA-881.00K | ILA10.00K | ILA891.00K | ▼ -8181.1 pp |
| 2010 | -628.9% | ILA-38.19 Million | ILA6.07 Million | ILA44.26 Million | ▼ -609.9 pp |
| 2009 | -19.0% | ILA-9.38 Million | ILA49.39 Million | ILA58.77 Million | ▼ -42.3 pp |
| 2008 | 23.4% | ILA11.86 Million | ILA50.81 Million | ILA38.94 Million | — |